FDA Should Speed Waiver Process For Lot Release Tests During Emergencies
This article was originally published in The Gray Sheet
Executive Summary
The Federal Office of Homeland Security should coordinate the distribution of diagnostic equipment and other blood testing products during emergencies, according to Johnson & Johnson/Ortho-Clinical Diagnostics' Director of Reimbursement and Health Policy Susan Reardon